TCS 184

CAS: 1315378-71-2

Ref. 3D-QCC37871

Produktinformation

• Name: TCS 184
• Marke: Biosynth
• Beschreibung: TCS 184 is a synthetic glycogen synthase kinase 3 (GSK-3) inhibitor that has been shown to increase the level of glycogen in cultured cells. TCS 184 was also found to inhibit glycogen synthase activity and decrease glucose uptake. The enzyme GSK-3 is involved in the assembly of glycogen, and inhibiting this enzyme leads to increased levels of glycogen. TCS 184 can be used for culturing cells as it does not require oxygen for its synthesis. This drug can be used for short-term studies as it does not have long-term effects on cells. TCS 184 also inhibits GSK-3, which is involved in the regulation of endoderm and extraembryonic tissue development during early embryonic development.

Chemische Eigenschaften

• Molekulargewicht: 1,425.6 g/mol
• Formel: C₅₈H₉₆N₂₀O₂₀S
• Reinheit: Min. 95%